<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE collection SYSTEM "BioC.dtd">
<collection><source>PMC</source><date>20201215</date><key>pmc.key</key><document><id>2658734</id><infon key="license">CC BY-NC</infon><passage><infon key="alt-title">Nephrol Dial Transplant (2009) 24: Editorial Reviews</infon><infon key="article-id_doi">10.1093/ndt/gfn728</infon><infon key="article-id_pmc">2658734</infon><infon key="article-id_pmid">19145005</infon><infon key="article-id_publisher-id">gfn728</infon><infon key="fpage">1088</infon><infon key="issue">4</infon><infon key="journal-title">Nephrology Dialysis Transplantation</infon><infon key="kwd">diabetes epigenetics microRNA podocyte</infon><infon key="license">The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org</infon><infon key="lpage">1096</infon><infon key="name_0">surname:Muhonen;given-names:Pirkko</infon><infon key="name_1">surname:Holthofer;given-names:Harry</infon><infon key="section_type">TITLE</infon><infon key="title">Keywords</infon><infon key="type">front</infon><infon key="volume">24</infon><infon key="year">2009</infon><offset>0</offset><text>Epigenetic and microRNA-mediated regulation in diabetes</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>56</offset><text>Introduction</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>69</offset><text>The increase in adult type diabetes is becoming a global epidemic and calls for swift actions to better understand the disease mechanisms, thus leading to improved targeted therapies. Emerging knowledge surrounding the role of microRNAs (miRNAs) in the regulation of post-transcriptional protein expression has dramatically altered the view of how target genes are regulated and how they are involved also in controlling glucose homeostasis. In addition to an improved understanding of miRNA functions, epigenetic control mechanisms are becoming better known. Thus, for example the effect of prenatal nutritional deficiencies and hereditary epigenetic changes, including DNA methylation and histone modifications are emerging as important players in the finely tuned balance of factors ultimately yielding the altered functions under various pathologic conditions.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>934</offset><text>In this article, we review the current understanding of the major epigenetic and post-transcriptional regulatory mechanisms with particular emphasis on podocytes during their injury associated with diabetic kidney damage. It is foreseen that this research line will bring major advances in diagnostics and understanding of pathomechanisms of both type 1 and 2 diabetes and will lead to identification of novel biomarkers and therapeutic targets.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>1380</offset><text>Epigenetic regulation</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>1402</offset><text>The term epigenetics is typically defined as heritable changes in gene expression that are not encoded directly within the DNA sequence of genes. Epigenetic changes are crucial for the development and differentiation of the various cell types in an organism. However, epigenetic states can become disrupted by environmental influences or during ageing, and the importance of epigenetic changes in the development of cancer and other diseases is increasingly being discovered.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>1878</offset><text>Eukaryotic genomes are packaged in two general varieties of chromatin: gene-rich euchromatin and genetically inactive heterochromatin. Heterochromatin is a tightly packaged form of DNA, and its major characteristic is that DNA transcription is limited. Centromeres and telomeres are both heterochromatic (Figure 1). The euchromatin, in contrast, contains âactiveâ chromatin: DNA sequences that are being transcribed into RNA. Heterochromatin replicates in the S phase (synthesis phase) of the cell cycle later than euchromatin, most likely preserving DNA structure during replication. Heterochromatin also maintains a compact and visible structure during mitosis therefore differing from euchromatin, which undergoes a typical cycle of condensation and unravelling during this process.</text></passage><passage><infon key="file">gfn728fig1.jpg</infon><infon key="id">F1</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>2668</offset><text>Schematic figure of chromatin and histone structure. Chromatin is the complex of DNA and protein that makes up chromosomes. Heterochromatin locates in the centromeric region and telomeres whereas transcritpionally active euchromatin is located in the less condensed region. The functions of chromatin are to package DNA into a smaller volume to fit in the cell, to strengthen the DNA to allow mitosis and meiosis and to serve as a mechanism to control expression. The major proteins involved in chromatin are histone proteins. The flexible N-terminal tails of the four core histones H2A, H2B, H3 and H4 may undergo a range of post-translational modifications, including acetylation, methylation, O-GlcNac modification, phosphorylation and ubiquitination, all leading to changes in the gene expression level.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>3476</offset><text>The DNA packaging densities of these two chromatin types vary along the length of the chromosome. High-density heterochromatin regions surround the centromeric region of the chromosome and have a low amount of expressed genes but a high content of repetitive DNA sequences including transposons, which are mobile genetic elements, and highly repetitive DNA regions called satellite DNAs. These two chromatin states are controlled by reversible epigenetic patterns of DNA methylation and histone modifications that changes gene expression without involving changes in the DNA sequence (Figure 2A and B).</text></passage><passage><infon key="file">gfn728fig2.jpg</infon><infon key="id">F2</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>4079</offset><text>Schematic figure of epigenetic regulation mechanism. DNA methylase catalyze the transfer of a methyl group to the cytosine residues in CpG dinucleotide sequences (A). Methylation of the CpG islands in the gene promoter region inhibits gene expression (B). Histone acetylation plays an important role in the regulation of gene expression. Hyperacetylated chromatin is transcriptionally active whereas hypoacetylated chromatin is silent. Methyl-CpG-binding proteins interact with histone deacetylase causing gene silencing (C).</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>4605</offset><text>Heterochromatin has diverse known and postulated functions: maintenance of genome stability, proper chromosomal segregation during mitosis and prevention of telomere fusion. Heterochromatin also regulates gene expression by both repression and activation, by directly silencing genes or by removal of silencing hallmarks of gene expression. These mechanisms result in considerable regulatory functions during development and in different physiologic states of cells.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>5072</offset><text>In addition to the heterochromatin diversity, the mammalian genome contains well-defined sequences, which notably consist of repeats of cytocine-phosphate-guanidine (CpG) motifs. These areas were earlier considered as non-functional redundant domains of the chromosomes during evolution while recent research has revealed strong regulatory functions to these elements mainly in influencing histone modifications and gene-silencing networks within the cells.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>5530</offset><text>In general, the epigenetic regulation of gene transcriptionâtranslation machinery consists of now known multiple mechanisms for modifying the readout of the genetic code and repression of the chromatin state. In the context of DNA methylation, sequences within the genome can be classified into two different groups: CpG-deprived regions and CpG-rich regions called âCpG islandsâ (see Figure 2). CpG islands are defined as being longer than 500 bp and having a GC base content &gt;55%. Considering their regulatory role, CpG islands are often found in promoter regions and about half of all genes contain CpG islands that are situated at the end of the 5â² region. Altered methylation status of GC-rich regions may alter the chromatin structure and typically modulates the finely tuned promoter-transcription factor interactions with the transcriptional machinery. This alteration leads to repressed gene expression associated with hypermethylated CpG islands. In contrast, genomic instability and aberrant gene expression have been associated with hypomethylated islands. It has been proposed that more than half of the repeating 5â²-CpG island sequences ultimately participate in transcription regulation as a result of methylation.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>6770</offset><text>Histones are core proteins involved in DNA assembly and yielding chromatin structure. Histones may dynamically undergo post-translational modifications, which alter their interaction with DNA and nuclear proteins. The flexible N-terminal tails of the four core histones (H2A, H2B, H3 and H4, see Figure 1) may undergo a range of post-translational modifications, including acetylation, methylation, O-GlcNac modification, phosphorylation and ubiquitination all leading to changes of the genetic readout. Histone modifications are indicators of active or repressed chromatin, and the âhistone codeâ hypothesis proposes that combinations of specific histone modifications create a complex defining the functional hierarchy for chromatin regulation.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>7521</offset><text>Key enzyme families involved in histone modification include histone acetyltransferases (HATs), histone deacetylases (HDACs), histone methyltransferases and the methyl-binding domain protein MECP2. Whereas methylation of lysine-9 of the histone structure defined as (H3-K9) is a hallmark of âsilencedâ genomic area throughout heterochromatic regions, the methylation of lysine 4 of histone H3 (H3-K4) denotes gain of activity and is found predominantly at the promoter areas of active genes. The evidence that several methyl-CpG-binding proteins interact with histone deacetylase supports a mechanism linking DNA methylation and histone modifications together (Figure 2C). In addition, DNA methylation of CpG-rich regions has recently been connected to histone deacetylation, methylation of histone H3 at a specific site of lysine 9 as well as to direct interference by small RNAs.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>8407</offset><text>Taken together, remarkable progress has been made in the understanding of the epigenetic mechanisms by which the gene readout can be modulated and changes in gene expression patterns achieved without assuming changes in the gene coding sequence. While the present understanding may already explain a substantial level of epigenetic regulation, a comprehensive understanding bringing all the elements together in understanding distinct pathophysiologic entities still remains to be established.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>8901</offset><text>MicroRNA biogenesis</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>8921</offset><text>MicroRNAs are single-stranded transcribed RNAs of 19â25 nucleotides in length that are generated from endogenous hairpin structured transcripts throughout the genome. Recent studies have shown that miRNAs have pivotal roles in diverse gene regulatory pathways, including e.g. control of timing of developmental processes, haematopoietic cell differentiation, apoptosis, cell proliferation and organ development. MicroRNAs also represent one of the largest gene families, accounting for â¼2% of the whole genome. Efforts to identify the specific miRNA targets have lead to speculations that miRNAs can directly regulate the imprint of &gt;90% of human genes. Their defined functions as key post-transcriptional regulatory mediators are rapidly emerging and have shown to be involved in the pathogenesis of a variety of diseases, including type 2 diabetes (see Table 1). Even now little is known of direct miRNA effects in the regulation of the functional kidney filtration barrier.</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>9902</offset><text>Validated and hypothetic miRNA targets</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;colgroup span=&quot;1&quot;&gt;&lt;col align=&quot;left&quot; span=&quot;1&quot;/&gt;&lt;col align=&quot;left&quot; span=&quot;1&quot;/&gt;&lt;col align=&quot;left&quot; span=&quot;1&quot;/&gt;&lt;col align=&quot;left&quot; span=&quot;1&quot;/&gt;&lt;/colgroup&gt;&lt;thead&gt;&lt;tr&gt;&lt;th colspan=&quot;4&quot; align=&quot;left&quot; rowspan=&quot;1&quot;&gt;Validated miRNA targets in type 2 diabetes and in the endocrine system&lt;/th&gt;&lt;/tr&gt;&lt;tr&gt;&lt;th align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;miRNA&lt;/th&gt;&lt;th align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Target&lt;/th&gt;&lt;th align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Function&lt;/th&gt;&lt;th align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Reference&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;miR-375&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Myotrophin&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Inhibition of insulin secretion&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref ref-type=&quot;bibr&quot; rid=&quot;R69&quot;&gt;69&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;miR-9&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;OneCut2 transcription factor&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Inhibition of glucose-stimulated insulin release&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref ref-type=&quot;bibr&quot; rid=&quot;R70&quot;&gt;70&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;miR-192&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;E-box repressors&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;TGF-beta-induced matrix protein collagen Col1a1 and -2&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref ref-type=&quot;bibr&quot; rid=&quot;R24&quot;&gt;24&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;miR-143&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;GLUT4, HSL, fatty acid-binding protein aP2, PPAR-Î¼2&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Adipocyte differentiation&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref ref-type=&quot;bibr&quot; rid=&quot;R49&quot;&gt;49&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;4&quot; align=&quot;left&quot; rowspan=&quot;1&quot;&gt;Hypothetic miRNA targets associated with type 2 diabetes&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;miR-30 family&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Receptor for advanced glycation end product, immediate early response 3, vimentin, heat-shock protein-20&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Podocyte apoptosis and cytoskeletal structure&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref ref-type=&quot;bibr&quot; rid=&quot;R79 R80&quot;&gt;79,80&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;miR-23b&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Hairy/enhancer of the split protein (Hes1)&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Downstream target of activated Notch signalling and expressed in nephron segments during development&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref ref-type=&quot;bibr&quot; rid=&quot;R81&quot;&gt;81&lt;/xref&gt;&lt;xref ref-type=&quot;bibr&quot; rid=&quot;R84&quot;&gt;84&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;miR-15, miR-16&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Wnt and Î²-catenin&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Nephron induction during embryo development&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref ref-type=&quot;bibr&quot; rid=&quot;R75 R76&quot;&gt;75,76&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;miR-7&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;GY-box&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Notch signalling&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref ref-type=&quot;bibr&quot; rid=&quot;R73 R74&quot;&gt;73,74&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;miR-4, miR-79&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Brd-box&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;miR-2, miR-11&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;K-box&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>9941</offset><text>Validated miRNA targets in type 2 diabetes and in the endocrine system	 	miRNA	Target	Function	Reference	 	miR-375	Myotrophin	Inhibition of insulin secretion		 	miR-9	OneCut2 transcription factor	Inhibition of glucose-stimulated insulin release		 	miR-192	E-box repressors	TGF-beta-induced matrix protein collagen Col1a1 and -2		 	miR-143	GLUT4, HSL, fatty acid-binding protein aP2, PPAR-Î¼2	Adipocyte differentiation		 	Hypothetic miRNA targets associated with type 2 diabetes	 	miR-30 family	Receptor for advanced glycation end product, immediate early response 3, vimentin, heat-shock protein-20	Podocyte apoptosis and cytoskeletal structure		 	miR-23b	Hairy/enhancer of the split protein (Hes1)	Downstream target of activated Notch signalling and expressed in nephron segments during development		 	miR-15, miR-16	Wnt and Î²-catenin	Nephron induction during embryo development		 	miR-7	GY-box	Notch signalling		 	miR-4, miR-79	Brd-box			 	miR-2, miR-11	K-box			 	</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>10911</offset><text>Biogenesis of miRNAs starts in the nucleus (see Figure 3) where stretches of several kilobases long primary miRNAs (pri-miRNAs) are transcribed from the genome, 3â²-polyadenylated [covalent linkage poly (A) tail of 3â² end of miRNA], 5â²-capped [7-methyl guanylate (m7G) cap of 5â² end of miRNA]. Pri-miRNAs are further modified by a microprocessor that consists of Drosha, a nuclear RNase-III enzyme, and its essential cofactor called Pasha. This resulting protein complex processes pri-miRNAs into â¼70 nucleotide (nt)-long hairpin-shaped premature miRNAs (pre-miRNAs), and the subsequent cleavage at approximately two helical turns from the loop structure. Pre-miRNAs bear a two nt 3â²-overhang that contributes to pre-miRNA export out of the nucleus to the cytoplasm by a RanGTP/exportin-5-dependent mechanism. Dicer, a cytoplasmic RNaseIII enzyme, then subjects pre-miRNA to a second cleavage step in the cytoplasm. Dicer cleaves near the hairpin loop to release a short, â¼22 base-pair (bp)-long incomplete RNA duplex with characteristic two nt-long 3â²-overhangs at both ends that anchor miRNA molecules to the miRNA-induced silencing complex miRISC. The miRNA strand having lower thermodynamic stability at its 5â²-end is selectively identified by miRISC and incorporated into miRISC that contains an Argonaute protein that is the catalytic component of RISC, and other protein factors. When activated by miRNA, miRISC acts as an effector complex of the miRNA pathway interacting with messenger RNA (mRNA). There are several proposed and verified mechanisms regarding how these genome-originated miRNAs can modulate gene and protein expression. It has been shown that miRNAs exhibiting full complementarity with target mRNA elicit mRNA degradation via a mechanism shared with short interfering RNAs (siRNAs). However, in cases of non-perfect complementary binding to the target mRNA 3â²-untranslated region (3â²-UTR), miRISC may hinder protein translation by several different mechanisms (Figure 3). These mechanisms include translational inhibition at the level of initiation and elongation, degradation of mRNA or the immature protein products or mRNA segregation into P bodies for translational inhibition and/or by mRNA deadenylation that causes destabilization of mRNA. The outcome of all these mechanisms either singularly or acting in combination is an effective regulation of the final mRNA yielding protein expression.</text></passage><passage><infon key="file">gfn728fig3.jpg</infon><infon key="id">F3</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>13358</offset><text>MicroRNA genesis. Long stretches of immature pri-miRNAs are transcribed from the genome, Drosha and its microprocessor partner Pasha processes pri-miRNAs into â¼70 nt long hairpin-shaped pre-miRNAs. Pre-miRNAs are exported out of the nucleus to the cytoplasm by the RanGTP/exportin-5-dependent mechanism. Dicer cleaves pre-miRNAs near the hairpin loop to release a short â¼22 base-pair (bp) long imperfect RNA duplexes that are further incorporated into the miRISC complex. MiRNAs exhibiting full complementarity with target messenger RNA (mRNA) are shown to prompt mRNA degradation. MiRISC may also hinder protein translation by several different distinct mechanism including translational inhibition at the level of initiation and elongation, degradation of mRNA or the immature protein products or mRNA are segregated into P bodies for translational inhibition and/or mRNA deadenylation that causes destabilization of mRNA.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>14287</offset><text>Tools to generate epigenetic and post-transcriptional profiles</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>14350</offset><text>Individual gene expression outcomes in complex diseases, typically in metabolic disorders such as type 2 diabetes, are unlikely to completely explain their impact on disease pathogenesis. Multiple factors are normally needed to manifest any polygenic human disease. In addition to DNA mutations and protein post-translational modifications, well-known factors typically include a complexity of environmental, dietary and exercise factors while the epigenetic regulatory mechanisms and any combinations of the convoluted mechanisms involved appear to be responsible in an increasing number of disease outcomes. Present day DNA analytics using robust techniques of, for example, genome-wide sequencing and mapping of global single nucleotide polymorphisms (SNPs), may thus not ultimately yield sufficient knowledge to understand disease pathogenesis. In combination with the new high-capacity array technologies, a new balance between global genomics, epigenetic gene regulation and post-transcriptional effects on protein landscape integrating the distinct data streams is needed to build a comprehensive understanding of underlying disease mechanisms in detail.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>15512</offset><text>The huge screening capacity provided by modern microarrays enable the study of individual factors involved in disease pathogenesis on a genome-wide scale simultaneously. A wide range of approaches is rapidly emerging to track the gene targets under epigenetic regulation and to determine the global changes in genomic DNA methylation. Customized combinations of these approaches, based on individual requirements, pave the way to an in-depth understanding of the processes involved and, hopefully, will yield better understanding for improved diagnostics and for example new targets for better therapies.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>16117</offset><text>Computational public database analysis [available e.g. at National Center for Biotechnology Information (NCBI, http://www.ncbi.nlm.nih.gov/), UCSC Genome Bioinformatics group, University of California, Santa Cruz, http:// genome.ucsc.edu/] is a key step in analysing and locating CpG islands in the promoter region of genes of interest. Considerable advances have been made in hybridization-based microarray technologies for genome-wide analysis for DNA methylation that is designed to discriminate between methylated and unmethylated sequences in gene promoters. A variety of other tools (see Table 2) for genome-wide discovery of differentially methylated sites include restriction mapping, bisulfite nucleotide sequencing, PCR amplification and chromatin immunoprecipitation on DNA microarray (ChIP-on-chip; for an excellent recent review of the techniques see Ho and Tang).</text></passage><passage><infon key="file">T2.xml</infon><infon key="id">T2</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>16995</offset><text>Techniques to analyse DNA methylation</text></passage><passage><infon key="file">T2.xml</infon><infon key="id">T2</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;colgroup span=&quot;1&quot;&gt;&lt;col align=&quot;left&quot; span=&quot;1&quot;/&gt;&lt;col align=&quot;left&quot; span=&quot;1&quot;/&gt;&lt;col align=&quot;left&quot; span=&quot;1&quot;/&gt;&lt;/colgroup&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Method&lt;/th&gt;&lt;th align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Description&lt;/th&gt;&lt;th align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Reference&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Methylation-sensitive restriction mapping (MSRF)&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PCR-based method for genomic DNA after &lt;italic&gt;Bst&lt;/italic&gt;U1 (CG specific, methylation sensitive) and/or &lt;italic&gt;Mse&lt;/italic&gt;I (non-CG specific) digestion&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref ref-type=&quot;bibr&quot; rid=&quot;R85&quot;&gt;85&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Restriction landmark genomic scanning (RLGS)&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Genome-wide screening method based on two dimensional separation of genomic DNA fragments containing radiolabel at the &lt;italic&gt;Not&lt;/italic&gt;I restriction sites (GC-rich regions)&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref ref-type=&quot;bibr&quot; rid=&quot;R86&quot;&gt;86&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Methylated CG island amplification (MCA)&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Amplification of DNA sequences with closely spaced (&amp;lt;1 kb) methylated &lt;italic&gt;Sma&lt;/italic&gt;I sites that are commonly found in CG islands&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref ref-type=&quot;bibr&quot; rid=&quot;R87&quot;&gt;87&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Differential methylation hybridization (DMH)&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Array-based method allows genome-wide screening of differentially methylated CG islands between two samples&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref ref-type=&quot;bibr&quot; rid=&quot;R88&quot;&gt;88&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Bisulphite sequencing&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Sequencing-based method. Bisulfite treatment of genomic DNA converts cytosine to uracil, but 5-methylcytosine remains nonreactive&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref ref-type=&quot;bibr&quot; rid=&quot;R89&quot;&gt;89&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Methylation-specific oligonucleotide array (MSO)&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Array-based high throughput method. Detection of methylation status of GC-rich genomic DNA fragments by comparison of signal intensities between the paired âmethylatedâ and âunmethylatedâ oligonucleotide probes&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref ref-type=&quot;bibr&quot; rid=&quot;R90&quot;&gt;90&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;DNA demethylating agents and gene expression analysis&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Detection of reactivated gene expression after treatment of DNA demethylating agent (e.g. 5-aza-2â²deoxycytosine) by gene expression microarrays&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref ref-type=&quot;bibr&quot; rid=&quot;R38&quot;&gt;38&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Genome-wide methylation array/promoter array&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Human and mouse CpG island/promoter arrays are constructed based on the CG island library containing CG-rich DNA fragments. University Health Network Microarray Center (UHNMC, Toronto, www.microarray.ca)&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref ref-type=&quot;bibr&quot; rid=&quot;R91&quot;&gt;91&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Chromatin immunoprecipitation on DNA microarray (ChIP-chip)&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;The DNA fragments isolated from chromatin immunoprecipitation assay are used as targets in a microarray&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref ref-type=&quot;bibr&quot; rid=&quot;R92&quot;&gt;92&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS)&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Method is based on analysis and precise quantification of methylation on CpG positions and patterns in genomic DNA by MALDI-TOF-MS&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref ref-type=&quot;bibr&quot; rid=&quot;R93&quot;&gt;93&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>17033</offset><text>Method	Description	Reference	 	Methylation-sensitive restriction mapping (MSRF)	PCR-based method for genomic DNA after BstU1 (CG specific, methylation sensitive) and/or MseI (non-CG specific) digestion		 	Restriction landmark genomic scanning (RLGS)	Genome-wide screening method based on two dimensional separation of genomic DNA fragments containing radiolabel at the NotI restriction sites (GC-rich regions)		 	Methylated CG island amplification (MCA)	Amplification of DNA sequences with closely spaced (&lt;1 kb) methylated SmaI sites that are commonly found in CG islands		 	Differential methylation hybridization (DMH)	Array-based method allows genome-wide screening of differentially methylated CG islands between two samples		 	Bisulphite sequencing	Sequencing-based method. Bisulfite treatment of genomic DNA converts cytosine to uracil, but 5-methylcytosine remains nonreactive		 	Methylation-specific oligonucleotide array (MSO)	Array-based high throughput method. Detection of methylation status of GC-rich genomic DNA fragments by comparison of signal intensities between the paired âmethylatedâ and âunmethylatedâ oligonucleotide probes		 	DNA demethylating agents and gene expression analysis	Detection of reactivated gene expression after treatment of DNA demethylating agent (e.g. 5-aza-2â²deoxycytosine) by gene expression microarrays		 	Genome-wide methylation array/promoter array	Human and mouse CpG island/promoter arrays are constructed based on the CG island library containing CG-rich DNA fragments. University Health Network Microarray Center (UHNMC, Toronto, www.microarray.ca)		 	Chromatin immunoprecipitation on DNA microarray (ChIP-chip)	The DNA fragments isolated from chromatin immunoprecipitation assay are used as targets in a microarray		 	Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS)	Method is based on analysis and precise quantification of methylation on CpG positions and patterns in genomic DNA by MALDI-TOF-MS		 	</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>19040</offset><text>With current microarray methods, it is also possible to monitor the effects of DNA demethylating agents (e.g. 5-aza-2â²-deoxycytidine) or histone deacetylation inhibitors (HDACs) by exploring transcription profiles of reactivated genes. The approaches taken to distinguish miRNA expression signatures associated with kidney disorders differ from approaches used to assay DNA methylation levels because miRNAs interfere at the post-transcriptional level while DNA methylation influences the transcription of the genome expression. In addition, it is a challenge to validate the miRNA target sequences because several different miRNAs may bind to and cooperatively control a single mRNA target and, conversely, a single miRNA can bind to and regulate many different mRNA targets. Therefore, high-throughput methods supplemented with extensive in silico data analysis and the subsequent investigation of the regulation of miRNA-mediated protein translation typically consist of comparison of protein expression levels [e.g. difference gel eletrophoresis (DiGE), mass spectrometry (MS) and western Blot] alongside with microRNA expression levels (miRNA arrays, qPCR). Hybridization-based microarrays to detect miRNAs are based on miRBase Sequence database (http://microrna. sanger.ac.uk/) that is a searchable database of published miRNA sequences and their annotations. MiRBase Sequence database consists of over 5000 miRNA loci from 58 species, ranging from vertebrates and invertebrates to prokaryotes including viruses. Recently, next-generation sequencing (NGS) technology has been shown to be capable of producing millions of DNA sequence reads ranging from 35 to 250 base pairs in a single run (commercially available sequencers: Roche (454) GS FLX sequencer http://www.454.com/enabling-technology/ the-system.asp; Illumina/Solexa Genome analyser http:// www.illumina.com/; and the Applied Biosystems SOLiD system http://marketing.appliedbiosystems.com/mk/get/ SOLID_KNOWLEDGE_LANDING). This new technology provides multiple advantages when compared to gene expression microarray platforms, not least in discovering non-coding RNA sequences, especially novel microRNAs.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>21214</offset><text>The final in vitro miRNA-target validation should be brought together by using pre-miRNA structures or miRNA inhibitors as demonstrated by Tian et al. for example. Only a few in vitro validated miRNA targets have thus far been identified using the pre-miRNA hairpin structures that mimic natural miRNA molecules. These pre-miRNAs are computationally predicted sequences emerging from the miRBase Sequence databases and typically increase the natural miRNA effect. Distinct pre-miRNA vector constructs as well as synthetic miRNA mimics are available commercially for miRNA functional analyses and miRNA-target site validation (e.g. Systems Biosciences, Mountain View, CA, USA: pre-miRNA clones; Dharmacon, Inc. Lafayette, CO, USA: miRIDIAN miRNA Mimic Library; Ambion, Inc. Austin TX, USA: Pre-miRTM miRNA Precursor Molecules) for extensive miRNA target validation for in vitro and in vivo purposes. Recently, it was shown that synthetic single stranded mature miRNAs or hairpin pre-miRNA structures cannot replace endogenous miRNAs already present in RISC. This affects the validation of miRNA targets by exogenous miRNA mimic structures.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>22353</offset><text>Antisense DNA oligonucleotides (ASOs) and anti-miRNA oligonucleotides (AMOs, antagomirs) are considered as a practical approach for specific pharmacological inhibition of miRNA function. There are two suggested strategies to target miRNA function in vitro and in vivo. First, ASOs are designed for RNaseH-mediated targeted degradation of pri-miRNA molecules in nucleus. The stereochemistry at the 2â²-position of the ribose has been shown to be a major determinant in the target RNA-binding affinity and the activation of RNaseH. Most common chemical modifications are phosphorothioate (PS) backbone modification combined with 2â²-O-methyl (2â²-O-Me) or with 2â²-O-methoxyethyl (2â²-O-MOE) antisense RNA oligomers or mixed locked nucleic acid (LNA)-DNA ASOs. The base-pair interaction between mature miRNA and mRNA is another logical target for an inhibitor. AMOs are targeting mature miRNA molecules in cytoplasm and designed to block its function in miRISC. Whereas pre-miRNA structures and unmodified single stranded mature miRNA molecules were not able to dissociate endogenous miRNAs from RISC, chemically modified ribo-oligonucleotides have been shown to present with this potential. AMOs consist of chemical modifications of 2â²-ribose and/or phosphate backbone (including 2â²-O-Me, 2â²Fluoro, 2â²-O-MOE, LNAs and PS backbone modifications) essential in protecting AMOs against endonuclease-mediated degradation and in improving affinity to target miRNA molecules. MiRNAâmRNA base-pair interaction has successfully been interrupted by transfecting modified AMOs complementary to miRNAs leading to blockage of the miRNAâRISC complex. Esau et al. applied 2â²-O-MOE phosphorothioate-modified antisense RNA oligonucleotides targeting miRNAs and demonstrated the potential inhibition of adipocyte differentiation by a mir-143 antagomir.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>24206</offset><text>Epigenetic regulation in diabetes</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>24240</offset><text>Epigenetic modulating mechanisms have recently been established as a massive regulatory machine that cannot be ignored in searching for a new mechanistic understanding of metabolic syndrome, obesity and type 2 diabetes. Type 2 diabetes is typically characterized by a combination of peripheral insulin resistance with an insulin secretion defect that varies in severity. The known mechanisms for disrupted insulin secretion in type 2 diabetes include accumulated damage caused by hyperglycaemia, hyperlipidaemia and oxidative stress in combination. Oxidative stress and reactive oxygen species have been shown to directly affect DNA methylation pattern and histone organization, therefore tuning the expression of multiple genes. In addition, early nutritional status and possible intrauterine deprivation of nutrients have been shown to strongly impact the long-lasting DNA methylation effects directed at the genome readout with immediate effects on development. A proposed mechanism includes effects by dietary methyl and cofactor sources, such as vitamin B12 and folic acid linked to single-carbon metabolism providing the methyl groups for all biological methylation reactions. During embryonic development, the genome undergoes extensive demethylation followed by remethylation, and appropriate DNA methylation status must be maintained over the rounds of rapid cellular proliferation steps. Unbalanced methyl donors from nutrition during embryonic development may thus irreversibly affect the DNA methylation patterns. Therefore, extremes of nutritional availability and distinct environmental factors have been suggested to influence the epigenetic modifications in human genome and to enhance susceptibility to altered epigenetic pattern and later to metabolic disorders and adult chronic diseases. Epidemiological studies have indicated that sub- or super-optimal nutrient provision in utero may lead to specific chromatin modifications as described above and have been proposed as mechanisms associated with the world-wide epidemic of type 2 diabetes. To support this hypothesis, dietary protein restriction of pregnant rats typically associated with hypomethylation of e.g. the glucocorticoid receptor (GR) and peroxisome proliferator-activated receptor gamma (PPARÎ³). PPARÎ³ coactivator 1 Î± (protein PGC-1Î±, gene PPARGC1A) is a well-established node in the pathogenesis of diabetes and a master transcriptional coactivator of mitochondrial genes. Its expression is decreased and related to impaired ATP production as a consequence of reduced oxidative phosphorylation in patients with type 2 diabetes. It has also been reported that DNA methylation of the PPARGC1A promoter is increased in diabetic islets, demonstrating a plausible mechanism for reduced PPARGC1A mRNA expression and insulin secretion in pancreatic islets of patients with type 2 diabetes. Consequently, super-optimal methyl donors from nutrition may influence DNA methylation in the PPARGG1A promoter region and therefore represent a potential epigenetic cause for type 2 diabetes. Heterochromatin silencing and histone H3-K9 methylation of heterochromatin transcription and generation of heterochromatin-originated short interfering RNA (siRNA) molecules have been shown in fission yeasts. This epigenetic regulation has specifically been timed during the S-phase of the cell cycle in a temperature sensitive manner. In mammals, levels of DNA methylation correlate with age. This suggests that gene expression may be repressed over time. It has been shown that in the glomerulus ageing podocytes exhibit changed gene expression patterns. In addition, it has been shown that the developmental regulator Pax2 promotes assembly of an H3K4 methyltransferease complex through nuclear factor PTIP (Pax Transcription activation domain Interacting Protein). The PTIP complex localizes to a Pax2 DNA-binding sequence and recruits the methyltransferease complex. In the embryo, together, Pax2 and Pax8 are important to regulators inducing nephric structures in the intermediate mesoderm and urogenital epithelium. Therefore, Pax2 provides a kidney-specific locus for epigenetic modifications during development.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>28439</offset><text>In addition, it has been shown that some genes that become DNA hypermethylated and silenced in cancer cells require intact DICER function for the maintenance of their epigenetic status. These results support the hypothesis that RNA interference-mediated DNA methylation in cooperation with environmental responses modify the genetic risk factors and the epigenetic inheritance of heterochromatin.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>28836</offset><text>MicroRNAs in insulin release regulation and kidney actions</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>28895</offset><text>A subset of miRNAs has shown to be involved in metabolic regulation of glucose homeostasis (Table 1). However, only very few miRNA species have been fully characterized experimentally and most of their functions remain unknown. Pancreatic islet-specific miR-375 inhibits insulin secretion in mouse pancreatic Î²-cells by inhibiting the expression of the protein myotrophin. In addition, myotrophin, also known as V-1, has been shown to interact with an actin-capping protein inhibiting F-actin assembly, and to induce exocytosis of insulin granules. In another study, increasing the level of miR-9 resulted in a severe defect in glucose-stimulated insulin release by down-regulating the transcription factor Onecut2 (OC2). OC2 represses the activity and expression of Rab27a effector granuphilin, which is a key component of the machinery controlling insulin release. Also miR-192 levels have been shown to be increased in glomeruli isolated from streptozotocin-injected diabetic mice as well as diabetic mice db/db when compared to non-diabetic mice. MiR-192 was shown to regulate E-box repressors that are responsible for controlling TGF-Î² induced extracellular matrix proteins collagen 1-Î± 1 and 2 (Col1a1 and 2) expression. Col1a1 and 2 were shown to accumulate during diabetic nephropathy; therefore, these results suggest an potential role of miR-192 in kidney diseases.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>30281</offset><text>Recently, a correlation between elevated Notch signalling pathway gene expression and diabetic nephropathy has been shown, in concert with Gremlin, the gene associated with tubulointerstinal fibrosis in diabetic nephropathy, suggesting the presence of miRNAs and CpG islands as a potential regulatory strategy in this disease. Interestingly, distinct miRNAs appear to modify Notch pathways in Drosophila melanogaster with an effect in signalling cascades determining cell specification and development. Lai et al. showed that specific miRNAs regulated negative regulatory sequence motifs known as the GY box, the Brd box and the K box in the 3â² UTR of the Notch target genes. These regulatory boxes have been shown to serve as binding sites for miRNAs: GY-box is inhibited by miR-7, Brd-box by miR-4 and miR-79, K-box by miR-2 and miR-11; however, it remains to be determined whether these miRNAs regulate Notch signalling in diabetic nephropathy. MiR-143 has been experimentally shown to regulate genes that are crucial for adipocyte differentiation, (including GLUT4, HSL, fatty acid-binding protein aP2 and PPAR-Î³2) demonstrating a role for miRNAs in fat metabolism and in endocrine function in humans. In addition, miR-15 and miR-16 have been proposed to control the Wnt/Î²-catenin signalling pathway during the embryonal stage. Wnt/Î²-catenin signalling regulates the early events of nephrogenic induction during mouse kidney development; however, a regulatory role for miR-15 or -16 has not yet been demonstrated during this process.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>31829</offset><text>In the human kidney cortex, the renal glomerulus forms the biological sieve that allows the passage of water and small molecules while macromolecules e.g. albumin cannot normally pass beyond the filtration barrier. Podocytes surround the basement membrane of glomerular capillaries from the outside and present specialized structures, foot processes linked to each other forming the slit diaphragms. Therefore podocytes are considered to be critical for maintaining the functional filtration barrier and preventing albuminuria: alterations in slit diaphragm-associated genes result in severe proteinuria.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>32434</offset><text>While the association of podocytic miRNA and DNA methylation profiles in health and disease is an important topic to study, little is still known of the role of miRNAs for this complex. General differences in miRNA expression as well as in the proteome profile have been shown in the rat renal medulla and in the renal cortex region using the microRNA microarray. Very recent findings of podocyte-specific deletion of Dicer demonstrated a critical role for miRNA regulation in the progression of glomerular and tubular damage, and therefore the development of proteinuria. Dicer deletion in podocytes led to podocyte apoptosis and depletion; proteinuria was significant 3 weeks after birth in mouse models. Also the rapid progression of glomerular and tubular injury was prominent at week 3, and culminated in death several weeks later. Based on altered gene expression profile in podocyte-specific Dicer knock-down glomeruli, especially the miR-30 family has been highlighted as candidates participating in podocyte homestasis and pathogenesis of kidney diseases of podocyte origin. In another study with the podocyte-specific Dicer knock-out mice, it was noticed that expression of slit diaphragm proteins nephrin and podocin was decreased. In this study, mmu-miR-23b, mmu-miR24 and mmu-miR26a were implicated as critical to maintain the glomerular filtration barrier.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>33805</offset><text>The rapid emergence and advances in high throughput screening techniques facilitate focused research of both genome-wide and cell-specific epigenetic and post-transcriptional imprints in diabetes and kidney disease. Improved understanding and identification of new epigenetic and post-transcriptional regulatory mechanisms involved in the regulation of the key molecular complexes of podocytes will be of utmost importance in advancing diagnosis and novel biomarker development, and in future therapeutics.</text></passage><passage><infon key="section_type">REF</infon><infon key="type">title</infon><offset>34312</offset><text>References</text></passage><passage><infon key="fpage">29</infon><infon key="lpage">41</infon><infon key="name_0">surname:Dimitri;given-names:P</infon><infon key="name_1">surname:Corradini;given-names:N</infon><infon key="name_2">surname:Rossi;given-names:F</infon><infon key="pub-id_pmid">15612038</infon><infon key="section_type">REF</infon><infon key="source">Bioessays</infon><infon key="type">ref</infon><infon key="volume">27</infon><infon key="year">2005</infon><offset>34323</offset><text>The paradox of functional heterochromatin</text></passage><passage><infon key="fpage">762</infon><infon key="lpage">818</infon><infon key="name_0">surname:Heitz;given-names:E</infon><infon key="section_type">REF</infon><infon key="source">Jehrb Wiss Botanik</infon><infon key="type">ref</infon><infon key="volume">69</infon><infon key="year">1928</infon><offset>34365</offset><text>Das heterochromatin der Moose</text></passage><passage><infon key="fpage">R895</infon><infon key="lpage">R898</infon><infon key="name_0">surname:Elgin;given-names:SC</infon><infon key="name_1">surname:Grewal;given-names:SI.</infon><infon key="pub-id_pmid">14654010</infon><infon key="section_type">REF</infon><infon key="source">Curr Biol</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="year">2003</infon><offset>34395</offset><text>Heterochromatin: silence is golden</text></passage><passage><infon key="fpage">416</infon><infon key="lpage">418</infon><infon key="name_0">surname:Bailis;given-names:JM</infon><infon key="name_1">surname:Forsburg;given-names:SL.</infon><infon key="pub-id_pmid">15004523</infon><infon key="section_type">REF</infon><infon key="source">Cell Cycle</infon><infon key="type">ref</infon><infon key="volume">3</infon><infon key="year">2004</infon><offset>34430</offset><text>S phase assembly of centromeric heterochromatin and cohesion</text></passage><passage><infon key="fpage">707</infon><infon key="lpage">714</infon><infon key="name_0">surname:Piacentini;given-names:L</infon><infon key="name_1">surname:Fanti;given-names:L</infon><infon key="name_2">surname:Berloco;given-names:M</infon><infon key="pub-id_pmid">12756231</infon><infon key="section_type">REF</infon><infon key="source">J Cell Biol</infon><infon key="type">ref</infon><infon key="volume">161</infon><infon key="year">2003</infon><offset>34491</offset><text>Heterochromatin protein 1 (HP1) is associated with induced gene expression in Drosophila euchromatin</text></passage><passage><infon key="fpage">490</infon><infon key="lpage">495</infon><infon key="name_0">surname:Fuks;given-names:F.</infon><infon key="pub-id_pmid">16098738</infon><infon key="section_type">REF</infon><infon key="source">Curr Opin Genet Dev</infon><infon key="type">ref</infon><infon key="volume">15</infon><infon key="year">2005</infon><offset>34592</offset><text>DNA methylation and histone modifications: teaming up to silence genes</text></passage><passage><infon key="fpage">235</infon><infon key="lpage">240</infon><infon key="name_0">surname:Takai;given-names:D</infon><infon key="name_1">surname:Jones;given-names:PA.</infon><infon key="pub-id_pmid">12954087</infon><infon key="section_type">REF</infon><infon key="source">In Silico Biol</infon><infon key="type">ref</infon><infon key="volume">3</infon><infon key="year">2003</infon><offset>34663</offset><text>The CpG island searcher: a new WWW resource</text></passage><passage><infon key="fpage">6</infon><infon key="lpage">21</infon><infon key="name_0">surname:Bird;given-names:A.</infon><infon key="pub-id_pmid">11782440</infon><infon key="section_type">REF</infon><infon key="source">Genes Dev</infon><infon key="type">ref</infon><infon key="volume">16</infon><infon key="year">2002</infon><offset>34707</offset><text>DNA methylation patterns and epigenetic memory</text></passage><passage><infon key="fpage">168</infon><infon key="lpage">174</infon><infon key="name_0">surname:Baylin;given-names:SB</infon><infon key="name_1">surname:Herman;given-names:JG.</infon><infon key="pub-id_pmid">10729832</infon><infon key="section_type">REF</infon><infon key="source">Trends Genet</infon><infon key="type">ref</infon><infon key="volume">16</infon><infon key="year">2000</infon><offset>34754</offset><text>DNA hypermethylation in tumorigenesis: epigenetics joins genetics</text></passage><passage><infon key="fpage">455</infon><infon key="name_0">surname:Eden;given-names:A</infon><infon key="name_1">surname:Gaudet;given-names:F</infon><infon key="name_2">surname:Waghmare;given-names:A</infon><infon key="pub-id_pmid">12702868</infon><infon key="section_type">REF</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">300</infon><infon key="year">2003</infon><offset>34820</offset><text>Chromosomal instability and tumors promoted by DNA hypomethylation</text></passage><passage><infon key="fpage">1412</infon><infon key="lpage">1417</infon><infon key="name_0">surname:Saxonov;given-names:S</infon><infon key="name_1">surname:Berg;given-names:P</infon><infon key="name_2">surname:Brutlag;given-names:DL.</infon><infon key="pub-id_pmid">16432200</infon><infon key="section_type">REF</infon><infon key="source">Proc Natl Acad Sci USA</infon><infon key="type">ref</infon><infon key="volume">103</infon><infon key="year">2006</infon><offset>34887</offset><text>A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters</text></passage><passage><infon key="fpage">1074</infon><infon key="lpage">1080</infon><infon key="name_0">surname:Jenuwein;given-names:T</infon><infon key="name_1">surname:Allis;given-names:CD</infon><infon key="pub-id_pmid">11498575</infon><infon key="section_type">REF</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">293</infon><infon key="year">2001</infon><offset>34999</offset><text>Translating the histone code</text></passage><passage><infon key="fpage">835</infon><infon key="lpage">851</infon><infon key="name_0">surname:Kaleem;given-names:A</infon><infon key="name_1">surname:Hoessli;given-names:DC</infon><infon key="name_2">surname:Ahmad;given-names:I</infon><infon key="pub-id_pmid">17668447</infon><infon key="section_type">REF</infon><infon key="source">J Cell Biochem</infon><infon key="type">ref</infon><infon key="volume">103</infon><infon key="year">2008</infon><offset>35028</offset><text>Immediate-early gene regulation by interplay between different post-translational modifications on human histone H3</text></passage><passage><infon key="fpage">8695</infon><infon key="lpage">8700</infon><infon key="name_0">surname:Bernstein;given-names:BE</infon><infon key="name_1">surname:Humphrey;given-names:EL</infon><infon key="name_2">surname:Erlich;given-names:RL</infon><infon key="pub-id_pmid">12060701</infon><infon key="section_type">REF</infon><infon key="source">Proc Natl Acad Sci USA</infon><infon key="type">ref</infon><infon key="volume">99</infon><infon key="year">2002</infon><offset>35144</offset><text>Methylation of histone H3 Lys 4 in coding regions of active genes</text></passage><passage><infon key="fpage">89</infon><infon key="lpage">97</infon><infon key="name_0">surname:Klose;given-names:RJ</infon><infon key="name_1">surname:Bird;given-names:AP.</infon><infon key="pub-id_pmid">16403636</infon><infon key="section_type">REF</infon><infon key="source">Trends Biochem Sci</infon><infon key="type">ref</infon><infon key="volume">31</infon><infon key="year">2006</infon><offset>35210</offset><text>Genomic DNA methylation: the mark and its mediators</text></passage><passage><infon key="fpage">211</infon><infon key="lpage">217</infon><infon key="name_0">surname:Kawasaki;given-names:H</infon><infon key="name_1">surname:Taira;given-names:K.</infon><infon key="pub-id_pmid">15311210</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">431</infon><infon key="year">2004</infon><offset>35262</offset><text>Induction of DNA methylation and gene silencing by short interfering RNAs in human cells</text></passage><passage><infon key="fpage">281</infon><infon key="lpage">297</infon><infon key="name_0">surname:Bartel;given-names:DP.</infon><infon key="pub-id_pmid">14744438</infon><infon key="section_type">REF</infon><infon key="source">Cell</infon><infon key="type">ref</infon><infon key="volume">116</infon><infon key="year">2004</infon><offset>35351</offset><text>MicroRNAs: genomics, biogenesis, mechanism, and function</text></passage><passage><infon key="fpage">5794</infon><infon key="lpage">5804</infon><infon key="name_0">surname:Morita;given-names:K</infon><infon key="name_1">surname:Han;given-names:M.</infon><infon key="pub-id_pmid">17139256</infon><infon key="section_type">REF</infon><infon key="source">EMBO J</infon><infon key="type">ref</infon><infon key="volume">25</infon><infon key="year">2006</infon><offset>35408</offset><text>Multiple mechanisms are involved in regulating the expression of the developmental timing regulator lin-28 in Caenorhabditis elegans</text></passage><passage><infon key="fpage">2750</infon><infon key="lpage">2755</infon><infon key="name_0">surname:Georgantas;given-names:RW;suffix:3rd</infon><infon key="name_1">surname:Hildreth;given-names:R</infon><infon key="name_2">surname:Morisot;given-names:S</infon><infon key="pub-id_pmid">17293455</infon><infon key="section_type">REF</infon><infon key="source">Proc Natl Acad Sci USA</infon><infon key="type">ref</infon><infon key="volume">104</infon><infon key="year">2007</infon><offset>35541</offset><text>CD34 +hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control</text></passage><passage><infon key="fpage">13944</infon><infon key="lpage">13949</infon><infon key="name_0">surname:Cimmino;given-names:A</infon><infon key="name_1">surname:Calin;given-names:GA</infon><infon key="name_2">surname:Fabbri;given-names:M</infon><infon key="pub-id_pmid">16166262</infon><infon key="section_type">REF</infon><infon key="source">Proc Natl Acad Sci USA</infon><infon key="type">ref</infon><infon key="volume">102</infon><infon key="year">2005</infon><offset>35661</offset><text>miR-15 and miR-16 induce apoptosis by targeting BCL2</text></passage><passage><infon key="fpage">189</infon><infon key="lpage">197</infon><infon key="name_0">surname:Zhao;given-names:Y</infon><infon key="name_1">surname:Srivastava;given-names:D.</infon><infon key="pub-id_pmid">17350266</infon><infon key="section_type">REF</infon><infon key="source">Trends Biochem Sci</infon><infon key="type">ref</infon><infon key="volume">32</infon><infon key="year">2007</infon><offset>35714</offset><text>A developmental view of microRNA function</text></passage><passage><infon key="fpage">1203</infon><infon key="lpage">1217</infon><infon key="name_0">surname:Miranda;given-names:KC</infon><infon key="name_1">surname:Huynh;given-names:T</infon><infon key="name_2">surname:Tay;given-names:Y</infon><infon key="pub-id_pmid">16990141</infon><infon key="section_type">REF</infon><infon key="source">Cell</infon><infon key="type">ref</infon><infon key="volume">126</infon><infon key="year">2006</infon><offset>35756</offset><text>A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes</text></passage><passage><infon key="fpage">97</infon><infon key="lpage">104</infon><infon key="name_0">surname:Perera;given-names:RJ</infon><infon key="name_1">surname:Ray;given-names:A.</infon><infon key="pub-id_pmid">17402793</infon><infon key="section_type">REF</infon><infon key="source">BioDrugs</infon><infon key="type">ref</infon><infon key="volume">21</infon><infon key="year">2007</infon><offset>35867</offset><text>MicroRNAs in the search for understanding human diseases</text></passage><passage><infon key="fpage">3432</infon><infon key="lpage">3437</infon><infon key="name_0">surname:Kato;given-names:M</infon><infon key="name_1">surname:Zhang;given-names:J</infon><infon key="name_2">surname:Wang;given-names:M</infon><infon key="pub-id_pmid">17360662</infon><infon key="section_type">REF</infon><infon key="source">Proc Natl Acad Sci USA</infon><infon key="type">ref</infon><infon key="volume">104</infon><infon key="year">2007</infon><offset>35924</offset><text>MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors</text></passage><passage><infon key="fpage">861</infon><infon key="lpage">865</infon><infon key="name_0">surname:Cullen;given-names:BR.</infon><infon key="pub-id_pmid">15610730</infon><infon key="section_type">REF</infon><infon key="source">Mol Cell</infon><infon key="type">ref</infon><infon key="volume">16</infon><infon key="year">2004</infon><offset>36058</offset><text>Transcription and processing of human microRNA precursors</text></passage><passage><infon key="fpage">185</infon><infon key="lpage">191</infon><infon key="name_0">surname:Bohnsack;given-names:MT</infon><infon key="name_1">surname:Czaplinski;given-names:K</infon><infon key="name_2">surname:Gorlich;given-names:D.</infon><infon key="pub-id_pmid">14730017</infon><infon key="section_type">REF</infon><infon key="source">Rna</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="year">2004</infon><offset>36116</offset><text>Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs</text></passage><passage><infon key="fpage">195</infon><infon key="lpage">198</infon><infon key="name_0">surname:Macrae;given-names:IJ</infon><infon key="name_1">surname:Zhou;given-names:K</infon><infon key="name_2">surname:Li;given-names:F</infon><infon key="pub-id_pmid">16410517</infon><infon key="section_type">REF</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">311</infon><infon key="year">2006</infon><offset>36214</offset><text>Structural basis for double-stranded RNA processing by Dicer</text></passage><passage><infon key="fpage">1377</infon><infon key="lpage">1380</infon><infon key="name_0">surname:Tomari;given-names:Y</infon><infon key="name_1">surname:Matranga;given-names:C</infon><infon key="name_2">surname:Haley;given-names:B</infon><infon key="pub-id_pmid">15550672</infon><infon key="section_type">REF</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">306</infon><infon key="year">2004</infon><offset>36275</offset><text>A protein sensor for siRNA asymmetry</text></passage><passage><infon key="fpage">219</infon><infon key="lpage">230</infon><infon key="name_0">surname:Stefani;given-names:G</infon><infon key="name_1">surname:Slack;given-names:FJ.</infon><infon key="pub-id_pmid">18270516</infon><infon key="section_type">REF</infon><infon key="source">Nat Rev Mol Cell Biol</infon><infon key="type">ref</infon><infon key="volume">9</infon><infon key="year">2008</infon><offset>36312</offset><text>Small non-coding RNAs in animal development</text></passage><passage><infon key="fpage">1108</infon><infon key="lpage">1114</infon><infon key="name_0">surname:Nottrott;given-names:S</infon><infon key="name_1">surname:Simard;given-names:MJ</infon><infon key="name_2">surname:Richter;given-names:JD.</infon><infon key="pub-id_pmid">17128272</infon><infon key="section_type">REF</infon><infon key="source">Nat Struct Mol Biol</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="year">2006</infon><offset>36356</offset><text>Human let-7a miRNA blocks protein production on actively translating polyribosomes</text></passage><passage><infon key="fpage">16961</infon><infon key="lpage">16966</infon><infon key="name_0">surname:Humphreys;given-names:DT</infon><infon key="name_1">surname:Westman;given-names:BJ</infon><infon key="name_2">surname:Martin;given-names:DI</infon><infon key="pub-id_pmid">16287976</infon><infon key="section_type">REF</infon><infon key="source">Proc Natl Acad Sci USA</infon><infon key="type">ref</infon><infon key="volume">102</infon><infon key="year">2005</infon><offset>36439</offset><text>MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function</text></passage><passage><infon key="fpage">719</infon><infon key="lpage">723</infon><infon key="name_0">surname:Liu;given-names:J</infon><infon key="name_1">surname:Valencia-Sanchez;given-names:MA</infon><infon key="name_2">surname:Hannon;given-names:GJ</infon><infon key="pub-id_pmid">15937477</infon><infon key="section_type">REF</infon><infon key="source">Nat Cell Biol</infon><infon key="type">ref</infon><infon key="volume">7</infon><infon key="year">2005</infon><offset>36556</offset><text>MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies</text></passage><passage><infon key="fpage">S24</infon><infon key="lpage">S28</infon><infon key="name_0">surname:Romao;given-names:I</infon><infon key="name_1">surname:Roth;given-names:J.</infon><infon key="pub-id_pmid">18358250</infon><infon key="section_type">REF</infon><infon key="source">J Am Diet Assoc</infon><infon key="type">ref</infon><infon key="volume">108</infon><infon key="year">2008</infon><offset>36628</offset><text>Genetic and environmental interactions in obesity and type 2 diabetes</text></passage><passage><infon key="fpage">90</infon><infon key="lpage">93</infon><infon key="name_0">surname:Hanson;given-names:MA</infon><infon key="name_1">surname:Gluckman;given-names:PD.</infon><infon key="pub-id_pmid">18226060</infon><infon key="section_type">REF</infon><infon key="source">Basic Clin Pharmacol Toxicol</infon><infon key="type">ref</infon><infon key="volume">102</infon><infon key="year">2008</infon><offset>36698</offset><text>Developmental origins of health and disease: new insights</text></passage><passage><infon key="fpage">291</infon><infon key="lpage">302</infon><infon key="name_0">surname:Gresham;given-names:D</infon><infon key="name_1">surname:Dunham;given-names:MJ</infon><infon key="name_2">surname:Botstein;given-names:D.</infon><infon key="pub-id_pmid">18347592</infon><infon key="section_type">REF</infon><infon key="source">Nat Rev Genet</infon><infon key="type">ref</infon><infon key="volume">9</infon><infon key="year">2008</infon><offset>36756</offset><text>Comparing whole genomes using DNA microarrays</text></passage><passage><infon key="fpage">138</infon><infon key="lpage">143</infon><infon key="name_0">surname:Shi;given-names:H</infon><infon key="name_1">surname:Maier;given-names:S</infon><infon key="name_2">surname:Nimmrich;given-names:I</infon><infon key="pub-id_pmid">12461783</infon><infon key="section_type">REF</infon><infon key="source">J Cell Biochem</infon><infon key="type">ref</infon><infon key="volume">88</infon><infon key="year">2003</infon><offset>36802</offset><text>Oligonucleotide-based microarray for DNA methylation analysis: principles and applications</text></passage><passage><infon key="fpage">267</infon><infon key="lpage">282</infon><infon key="name_0">surname:Ho;given-names:SM</infon><infon key="name_1">surname:Tang;given-names:WY.</infon><infon key="pub-id_pmid">17317097</infon><infon key="section_type">REF</infon><infon key="source">Reprod Toxicol</infon><infon key="type">ref</infon><infon key="volume">23</infon><infon key="year">2007</infon><offset>36893</offset><text>Techniques used in studies of epigenome dysregulation due to aberrant DNA methylation: an emphasis on fetal-based adult diseases</text></passage><passage><infon key="fpage">181</infon><infon key="name_0">surname:Dannenberg;given-names:LO</infon><infon key="name_1">surname:Edenberg;given-names:HJ</infon><infon key="pub-id_pmid">16854234</infon><infon key="section_type">REF</infon><infon key="source">BMC Genomics</infon><infon key="type">ref</infon><infon key="volume">7</infon><infon key="year">2006</infon><offset>37022</offset><text>Epigenetics of gene expression in human hepatoma cells: expression profiling the response to inhibition of DNA methylation and histone deacetylation</text></passage><passage><infon key="fpage">787</infon><infon key="lpage">798</infon><infon key="name_0">surname:Lewis;given-names:BP</infon><infon key="name_1">surname:Shih;given-names:IH</infon><infon key="name_2">surname:Jones-Rhoades;given-names:MW</infon><infon key="pub-id_pmid">14697198</infon><infon key="section_type">REF</infon><infon key="source">Cell</infon><infon key="type">ref</infon><infon key="volume">115</infon><infon key="year">2003</infon><offset>37171</offset><text>Prediction of mammalian microRNA targets</text></passage><passage><infon key="fpage">404</infon><infon key="lpage">411</infon><infon key="name_0">surname:Tian;given-names:Z</infon><infon key="name_1">surname:Greene;given-names:AS</infon><infon key="name_2">surname:Pietrusz;given-names:JL</infon><infon key="pub-id_pmid">18230805</infon><infon key="section_type">REF</infon><infon key="source">Genome Res</infon><infon key="type">ref</infon><infon key="volume">18</infon><infon key="year">2008</infon><offset>37212</offset><text>MicroRNA-target pairs in the rat kidney identified by microRNA microarray, proteomic, and bioinformatic analysis</text></passage><passage><infon key="fpage">D154</infon><infon key="lpage">D158</infon><infon key="name_0">surname:Griffiths-Jones;given-names:S</infon><infon key="name_1">surname:Saini;given-names:HK</infon><infon key="name_2">surname:van Dongen;given-names:S</infon><infon key="pub-id_pmid">17991681</infon><infon key="section_type">REF</infon><infon key="source">Nucleic Acids Res</infon><infon key="type">ref</infon><infon key="volume">36</infon><infon key="year">2008</infon><offset>37325</offset><text>miRBase: tools for microRNA genomics</text></passage><passage><infon key="fpage">133</infon><infon key="lpage">141</infon><infon key="name_0">surname:Mardis;given-names:ER.</infon><infon key="pub-id_pmid">18262675</infon><infon key="section_type">REF</infon><infon key="source">Trends Genet</infon><infon key="type">ref</infon><infon key="volume">24</infon><infon key="year">2008</infon><offset>37362</offset><text>The impact of next-generation sequencing technology on genetics</text></passage><passage><infon key="fpage">47</infon><infon key="lpage">54</infon><infon key="name_0">surname:Kuhn;given-names:DE</infon><infon key="name_1">surname:Martin;given-names:MM</infon><infon key="name_2">surname:Feldman;given-names:DS</infon><infon key="pub-id_pmid">18158132</infon><infon key="section_type">REF</infon><infon key="source">Methods</infon><infon key="type">ref</infon><infon key="volume">44</infon><infon key="year">2008</infon><offset>37426</offset><text>Experimental validation of miRNA targets</text></passage><passage><infon key="fpage">24</infon><infon key="lpage">29</infon><infon key="name_0">surname:Tang;given-names:F</infon><infon key="name_1">surname:Hajkova;given-names:P</infon><infon key="name_2">surname:OâCarroll;given-names:D</infon><infon key="pub-id_pmid">18474225</infon><infon key="section_type">REF</infon><infon key="source">Biochem Biophys Res Commun</infon><infon key="type">ref</infon><infon key="volume">372</infon><infon key="year">2008</infon><offset>37467</offset><text>MicroRNAs are tightly associated with RNA-induced gene silencing complexes in vivo</text></passage><passage><infon key="fpage">55</infon><infon key="lpage">60</infon><infon key="name_0">surname:Esau;given-names:CC.</infon><infon key="pub-id_pmid">18158133</infon><infon key="section_type">REF</infon><infon key="source">Methods</infon><infon key="type">ref</infon><infon key="volume">44</infon><infon key="year">2008</infon><offset>37550</offset><text>Inhibition of microRNA with antisense oligonucleotides</text></passage><passage><infon key="fpage">2294</infon><infon key="lpage">2304</infon><infon key="name_0">surname:Davis;given-names:S</infon><infon key="name_1">surname:Lollo;given-names:B</infon><infon key="name_2">surname:Freier;given-names:S</infon><infon key="pub-id_pmid">16690972</infon><infon key="section_type">REF</infon><infon key="source">Nucleic Acids Res</infon><infon key="type">ref</infon><infon key="volume">34</infon><infon key="year">2006</infon><offset>37605</offset><text>Improved targeting of miRNA with antisense oligonucleotides</text></passage><passage><infon key="fpage">189</infon><infon key="lpage">208</infon><infon key="name_0">surname:Zamaratski;given-names:E</infon><infon key="name_1">surname:Pradeepkumar;given-names:PI</infon><infon key="name_2">surname:Chattopadhyaya;given-names:J.</infon><infon key="pub-id_pmid">11384757</infon><infon key="section_type">REF</infon><infon key="source">J Biochem Biophys Methods</infon><infon key="type">ref</infon><infon key="volume">48</infon><infon key="year">2001</infon><offset>37665</offset><text>A critical survey of the structure-function of the antisense oligo/RNA heteroduplex as substrate for RNase H</text></passage><passage><infon key="fpage">685</infon><infon key="lpage">689</infon><infon key="name_0">surname:Krutzfeldt;given-names:J</infon><infon key="name_1">surname:Rajewsky;given-names:N</infon><infon key="name_2">surname:Braich;given-names:R</infon><infon key="pub-id_pmid">16258535</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">438</infon><infon key="year">2005</infon><offset>37774</offset><text>Silencing of microRNAs in vivo with âantagomirsâ</text></passage><passage><infon key="fpage">52361</infon><infon key="lpage">52365</infon><infon key="name_0">surname:Esau;given-names:C</infon><infon key="name_1">surname:Kang;given-names:X</infon><infon key="name_2">surname:Peralta;given-names:E</infon><infon key="pub-id_pmid">15504739</infon><infon key="section_type">REF</infon><infon key="source">J Biol Chem</infon><infon key="type">ref</infon><infon key="volume">279</infon><infon key="year">2004</infon><offset>37827</offset><text>MicroRNA-143 regulates adipocyte differentiation</text></passage><passage><infon key="fpage">487</infon><infon key="lpage">502</infon><infon key="name_0">surname:Junien;given-names:C</infon><infon key="name_1">surname:Nathanielsz;given-names:P.</infon><infon key="pub-id_pmid">17949354</infon><infon key="section_type">REF</infon><infon key="source">Obes Rev</infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="year">2007</infon><offset>37876</offset><text>Report on the IASO Stock Conference 2006: early and lifelong environmental epigenomic programming of metabolic syndrome, obesity and type II diabetes</text></passage><passage><infon key="fpage">465</infon><infon key="lpage">469</infon><infon key="name_0">surname:Wallace;given-names:TM</infon><infon key="name_1">surname:Matthews;given-names:DR.</infon><infon key="pub-id_pmid">12060057</infon><infon key="section_type">REF</infon><infon key="source">Diabet Med</infon><infon key="type">ref</infon><infon key="volume">19</infon><infon key="year">2002</infon><offset>38026</offset><text>Coefficient of failure: a methodology for examining longitudinal beta-cell function in type 2 diabetes</text></passage><passage><infon key="fpage">581</infon><infon key="lpage">587</infon><infon key="name_0">surname:Robertson;given-names:RP</infon><infon key="name_1">surname:Harmon;given-names:J</infon><infon key="name_2">surname:Tran;given-names:PO</infon><infon key="pub-id_pmid">12606496</infon><infon key="section_type">REF</infon><infon key="source">Diabetes</infon><infon key="type">ref</infon><infon key="volume">52</infon><infon key="year">2003</infon><offset>38129</offset><text>Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection</text></passage><passage><infon key="fpage">141</infon><infon key="lpage">152</infon><infon key="name_0">surname:Cerda;given-names:S</infon><infon key="name_1">surname:Weitzman;given-names:SA.</infon><infon key="pub-id_pmid">9113115</infon><infon key="section_type">REF</infon><infon key="source">Mutat Res</infon><infon key="type">ref</infon><infon key="volume">386</infon><infon key="year">1997</infon><offset>38233</offset><text>Influence of oxygen radical injury on DNA methylation</text></passage><passage><infon key="fpage">1899</infon><infon key="lpage">1906</infon><infon key="name_0">surname:Gallou-Kabani;given-names:C</infon><infon key="name_1">surname:Junien;given-names:C.</infon><infon key="pub-id_pmid">15983188</infon><infon key="section_type">REF</infon><infon key="source">Diabetes</infon><infon key="type">ref</infon><infon key="volume">54</infon><infon key="year">2005</infon><offset>38287</offset><text>Nutritional epigenomics of metabolic syndrome: new perspective against the epidemic</text></passage><passage><infon key="fpage">255</infon><infon key="lpage">282</infon><infon key="name_0">surname:Van Den Veyver;given-names:IB.</infon><infon key="pub-id_pmid">12055346</infon><infon key="section_type">REF</infon><infon key="source">Annu Rev Nutr</infon><infon key="type">ref</infon><infon key="volume">22</infon><infon key="year">2002</infon><offset>38371</offset><text>Genetic effects of methylation diets</text></passage><passage><infon key="fpage">R47</infon><infon key="lpage">R58</infon><infon key="name_0">surname:Morgan;given-names:HD</infon><infon key="name_1">surname:Santos;given-names:F</infon><infon key="name_2">surname:Green;given-names:K</infon><infon key="pub-id_pmid">15809273</infon><infon key="section_type">REF</infon><infon key="source">Hum Mol Genet</infon><infon key="type">ref</infon><infon key="volume">14</infon><infon key="year">2005</infon><offset>38408</offset><text>Epigenetic reprogramming in mammals</text></passage><passage><infon key="fpage">179</infon><infon key="lpage">197</infon><infon key="name_0">surname:Waterland;given-names:RA</infon><infon key="name_1">surname:Garza;given-names:C.</infon><infon key="pub-id_pmid">9989679</infon><infon key="section_type">REF</infon><infon key="source">Am J Clin Nutr</infon><infon key="type">ref</infon><infon key="volume">69</infon><infon key="year">1999</infon><offset>38444</offset><text>Potential mechanisms of metabolic imprinting that lead to chronic disease</text></passage><passage><infon key="fpage">46</infon><infon key="lpage">57</infon><infon key="name_0">surname:Feil;given-names:R.</infon><infon key="pub-id_pmid">16854438</infon><infon key="section_type">REF</infon><infon key="source">Mutat Res</infon><infon key="type">ref</infon><infon key="volume">600</infon><infon key="year">2006</infon><offset>38518</offset><text>Environmental and nutritional effects on the epigenetic regulation of genes</text></passage><passage><infon key="fpage">105</infon><infon key="lpage">113</infon><infon key="name_0">surname:Devaskar;given-names:SU</infon><infon key="name_1">surname:Thamotharan;given-names:M.</infon><infon key="pub-id_pmid">17657604</infon><infon key="section_type">REF</infon><infon key="source">Rev Endocr Metab Disord</infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="year">2007</infon><offset>38594</offset><text>Metabolic programming in the pathogenesis of insulin resistance</text></passage><passage><infon key="fpage">64R</infon><infon key="lpage">67R</infon><infon key="name_0">surname:Simmons;given-names:RA.</infon><infon key="section_type">REF</infon><infon key="source">Pediatr Res</infon><infon key="type">ref</infon><infon key="volume">61</infon><infon key="year">2007</infon><offset>38658</offset><text>Developmental origins of beta-cell failure in type 2 diabetes: the role of epigenetic mechanisms</text></passage><passage><infon key="fpage">611</infon><infon key="lpage">638</infon><infon key="name_0">surname:Scarpulla;given-names:RC.</infon><infon key="pub-id_pmid">18391175</infon><infon key="section_type">REF</infon><infon key="source">Physiol Rev</infon><infon key="type">ref</infon><infon key="volume">88</infon><infon key="year">2008</infon><offset>38755</offset><text>Transcriptional paradigms in mammalian mitochondrial biogenesis and function</text></passage><passage><infon key="fpage">615</infon><infon key="lpage">622</infon><infon key="name_0">surname:Ling;given-names:C</infon><infon key="name_1">surname:Del Guerra;given-names:S</infon><infon key="name_2">surname:Lupi;given-names:R</infon><infon key="pub-id_pmid">18270681</infon><infon key="section_type">REF</infon><infon key="source">Diabetologia</infon><infon key="type">ref</infon><infon key="volume">51</infon><infon key="year">2008</infon><offset>38832</offset><text>Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion</text></passage><passage><infon key="fpage">490</infon><infon key="lpage">495</infon><infon key="name_0">surname:Kloc;given-names:A</infon><infon key="name_1">surname:Zaratiegui;given-names:M</infon><infon key="name_2">surname:Nora;given-names:E</infon><infon key="pub-id_pmid">18394897</infon><infon key="section_type">REF</infon><infon key="source">Curr Biol</infon><infon key="type">ref</infon><infon key="volume">18</infon><infon key="year">2008</infon><offset>38930</offset><text>RNA interference guides histone modification during the S phase of chromosomal replication</text></passage><passage><infon key="fpage">413</infon><infon key="lpage">418</infon><infon key="name_0">surname:Fraga;given-names:MF</infon><infon key="name_1">surname:Esteller;given-names:M.</infon><infon key="pub-id_pmid">17559965</infon><infon key="section_type">REF</infon><infon key="source">Trends Genet</infon><infon key="type">ref</infon><infon key="volume">23</infon><infon key="year">2007</infon><offset>39021</offset><text>Epigenetics and aging: the targets and the marks</text></passage><passage><infon key="fpage">2953</infon><infon key="lpage">2966</infon><infon key="name_0">surname:Wiggins;given-names:JE</infon><infon key="name_1">surname:Goyal;given-names:M</infon><infon key="name_2">surname:Sanden;given-names:SK</infon><infon key="pub-id_pmid">16120818</infon><infon key="section_type">REF</infon><infon key="source">J Am Soc Nephrol</infon><infon key="type">ref</infon><infon key="volume">16</infon><infon key="year">2005</infon><offset>39070</offset><text>Podocyte hypertrophy, âadaptation,â and âdecompensationâ associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction</text></passage><passage><infon key="fpage">580</infon><infon key="lpage">592</infon><infon key="name_0">surname:Patel;given-names:SR</infon><infon key="name_1">surname:Kim;given-names:D</infon><infon key="name_2">surname:Levitan;given-names:I</infon><infon key="pub-id_pmid">17925232</infon><infon key="section_type">REF</infon><infon key="source">Dev Cell</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="year">2007</infon><offset>39249</offset><text>The BRCT-domain containing protein PTIP links PAX2 to a histone H3, lysine 4 methyltransferase complex</text></passage><passage><infon key="fpage">2958</infon><infon key="lpage">2970</infon><infon key="name_0">surname:Bouchard;given-names:M</infon><infon key="name_1">surname:Souabni;given-names:A</infon><infon key="name_2">surname:Mandler;given-names:M</infon><infon key="pub-id_pmid">12435636</infon><infon key="section_type">REF</infon><infon key="source">Genes Dev</infon><infon key="type">ref</infon><infon key="volume">16</infon><infon key="year">2002</infon><offset>39352</offset><text>Nephric lineage specification by Pax2 and Pax8</text></passage><passage><infon key="fpage">2570</infon><infon key="lpage">2575</infon><infon key="name_0">surname:Ting;given-names:AH</infon><infon key="name_1">surname:Suzuki;given-names:H</infon><infon key="name_2">surname:Cope;given-names:L</infon><infon key="pub-id_pmid">18413723</infon><infon key="section_type">REF</infon><infon key="source">Cancer Res</infon><infon key="type">ref</infon><infon key="volume">68</infon><infon key="year">2008</infon><offset>39399</offset><text>A requirement for DICER to maintain full promoter CpG island hypermethylation in human cancer cells</text></passage><passage><infon key="fpage">226</infon><infon key="lpage">230</infon><infon key="name_0">surname:Poy;given-names:MN</infon><infon key="name_1">surname:Eliasson;given-names:L</infon><infon key="name_2">surname:Krutzfeldt;given-names:J</infon><infon key="pub-id_pmid">15538371</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">432</infon><infon key="year">2004</infon><offset>39499</offset><text>A pancreatic islet-specific microRNA regulates insulin secretion</text></passage><passage><infon key="fpage">26932</infon><infon key="lpage">26942</infon><infon key="name_0">surname:Plaisance;given-names:V</infon><infon key="name_1">surname:Abderrahmani;given-names:A</infon><infon key="name_2">surname:Perret-Menoud;given-names:V</infon><infon key="pub-id_pmid">16831872</infon><infon key="section_type">REF</infon><infon key="source">J Biol Chem</infon><infon key="type">ref</infon><infon key="volume">281</infon><infon key="year">2006</infon><offset>39564</offset><text>MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells</text></passage><passage><infon key="fpage">99</infon><infon key="lpage">109</infon><infon key="name_0">surname:Gomi;given-names:H</infon><infon key="name_1">surname:Mizutani;given-names:S</infon><infon key="name_2">surname:Kasai;given-names:K</infon><infon key="pub-id_pmid">16216924</infon><infon key="section_type">REF</infon><infon key="source">J Cell Biol</infon><infon key="type">ref</infon><infon key="volume">171</infon><infon key="year">2005</infon><offset>39673</offset><text>Granuphilin molecularly docks insulin granules to the fusion machinery</text></passage><passage><infon key="fpage">1034</infon><infon key="lpage">1039</infon><infon key="name_0">surname:Dolan;given-names:V</infon><infon key="name_1">surname:Murphy;given-names:M</infon><infon key="name_2">surname:Sadlier;given-names:D</infon><infon key="pub-id_pmid">15957132</infon><infon key="section_type">REF</infon><infon key="source">Am J Kidney Dis</infon><infon key="type">ref</infon><infon key="volume">45</infon><infon key="year">2005</infon><offset>39744</offset><text>Expression of gremlin, a bone morphogenetic protein antagonist, in human diabetic nephropathy</text></passage><passage><infon key="fpage">10</infon><infon key="lpage">21</infon><infon key="name_0">surname:Walsh;given-names:DW</infon><infon key="name_1">surname:Roxburgh;given-names:SA</infon><infon key="name_2">surname:McGettigan;given-names:P</infon><infon key="pub-id_pmid">17980714</infon><infon key="section_type">REF</infon><infon key="source">Biochim Biophys Acta</infon><infon key="type">ref</infon><infon key="volume">1782</infon><infon key="year">2008</infon><offset>39838</offset><text>Co-regulation of Gremlin and Notch signalling in diabetic nephropathy</text></passage><passage><infon key="fpage">1067</infon><infon key="lpage">1080</infon><infon key="name_0">surname:Lai;given-names:EC</infon><infon key="name_1">surname:Tam;given-names:B</infon><infon key="name_2">surname:Rubin;given-names:GM.</infon><infon key="pub-id_pmid">15833912</infon><infon key="section_type">REF</infon><infon key="source">Genes Dev</infon><infon key="type">ref</infon><infon key="volume">19</infon><infon key="year">2005</infon><offset>39908</offset><text>Pervasive regulation of Drosophila Notch target genes by GY-box-, Brd-box-, and K-box-class microRNAs</text></passage><passage><infon key="fpage">183</infon><infon key="lpage">188</infon><infon key="name_0">surname:Martello;given-names:G</infon><infon key="name_1">surname:Zacchigna;given-names:L</infon><infon key="name_2">surname:Inui;given-names:M</infon><infon key="pub-id_pmid">17728715</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">449</infon><infon key="year">2007</infon><offset>40010</offset><text>MicroRNA control of Nodal signalling</text></passage><passage><infon key="fpage">2533</infon><infon key="lpage">2539</infon><infon key="name_0">surname:Park;given-names:JS</infon><infon key="name_1">surname:Valerius;given-names:MT</infon><infon key="name_2">surname:McMahon;given-names:AP.</infon><infon key="pub-id_pmid">17537789</infon><infon key="section_type">REF</infon><infon key="source">Development</infon><infon key="type">ref</infon><infon key="volume">134</infon><infon key="year">2007</infon><offset>40047</offset><text>Wnt/beta-catenin signaling regulates nephron induction during mouse kidney development</text></passage><passage><infon key="fpage">483</infon><infon key="lpage">492</infon><infon key="name_0">surname:Patari-Sampo;given-names:A</infon><infon key="name_1">surname:Ihalmo;given-names:P</infon><infon key="name_2">surname:Holthofer;given-names:H.</infon><infon key="pub-id_pmid">17101539</infon><infon key="section_type">REF</infon><infon key="source">Ann Med</infon><infon key="type">ref</infon><infon key="volume">38</infon><infon key="year">2006</infon><offset>40134</offset><text>Molecular basis of the glomerular filtration: nephrin and the emerging protein complex at the podocyte slit diaphragm</text></passage><passage><infon key="fpage">423</infon><infon key="lpage">433</infon><infon key="name_0">surname:Rodewald;given-names:R</infon><infon key="name_1">surname:Karnovsky;given-names:MJ.</infon><infon key="pub-id_pmid">4204974</infon><infon key="section_type">REF</infon><infon key="source">J Cell Biol</infon><infon key="type">ref</infon><infon key="volume">60</infon><infon key="year">1974</infon><offset>40252</offset><text>Porous substructure of the glomerular slit diaphragm in the rat and mouse</text></passage><passage><infon key="fpage">2159</infon><infon key="lpage">2169</infon><infon key="name_0">surname:Shi;given-names:S</infon><infon key="name_1">surname:Yu;given-names:L</infon><infon key="name_2">surname:Chiu;given-names:C</infon><infon key="pub-id_pmid">18776119</infon><infon key="section_type">REF</infon><infon key="source">J Am Soc Nephrol</infon><infon key="type">ref</infon><infon key="volume">19</infon><infon key="year">2008</infon><offset>40326</offset><text>Podocyte-selective deletion of Dicer induces proteinuria and glomerulosclerosis</text></passage><passage><infon key="fpage">2150</infon><infon key="lpage">2158</infon><infon key="name_0">surname:Harvey;given-names:SJ</infon><infon key="name_1">surname:Jarad;given-names:G</infon><infon key="name_2">surname:Cunningham;given-names:J</infon><infon key="pub-id_pmid">18776121</infon><infon key="section_type">REF</infon><infon key="source">J Am Soc Nephrol</infon><infon key="type">ref</infon><infon key="volume">19</infon><infon key="year">2008</infon><offset>40406</offset><text>Podocyte-specific deletion of Dicer alters cytoskeletal dynamics and causes glomerular disease</text></passage><passage><infon key="fpage">2069</infon><infon key="lpage">2075</infon><infon key="name_0">surname:Ho;given-names:J</infon><infon key="name_1">surname:Ng;given-names:KH</infon><infon key="name_2">surname:Rosen;given-names:S</infon><infon key="pub-id_pmid">18832437</infon><infon key="section_type">REF</infon><infon key="source">J Am Soc Nephrol</infon><infon key="type">ref</infon><infon key="volume">19</infon><infon key="year">2008</infon><offset>40501</offset><text>Podocyte-specific loss of functional microRNAs leads to rapid glomerular and tubular injury</text></passage><passage><infon key="fpage">1481</infon><infon key="lpage">1491</infon><infon key="name_0">surname:Holzman;given-names:LB</infon><infon key="name_1">surname:St John;given-names:PL</infon><infon key="name_2">surname:Kovari;given-names:IA</infon><infon key="pub-id_pmid">10504499</infon><infon key="section_type">REF</infon><infon key="source">Kidney Int</infon><infon key="type">ref</infon><infon key="volume">56</infon><infon key="year">1999</infon><offset>40593</offset><text>Nephrin localizes to the slit pore of the glomerular epithelial cell</text></passage><passage><infon key="fpage">131</infon><infon key="lpage">139</infon><infon key="name_0">surname:Roselli;given-names:S</infon><infon key="name_1">surname:Gribouval;given-names:O</infon><infon key="name_2">surname:Boute;given-names:N</infon><infon key="pub-id_pmid">11786407</infon><infon key="section_type">REF</infon><infon key="source">Am J Pathol</infon><infon key="type">ref</infon><infon key="volume">160</infon><infon key="year">2002</infon><offset>40662</offset><text>Podocin localizes in the kidney to the slit diaphragm area</text></passage><passage><infon key="fpage">F939</infon><infon key="lpage">F952</infon><infon key="name_0">surname:Chen;given-names:L</infon><infon key="name_1">surname:Al-Awqati;given-names:Q.</infon><infon key="pub-id_pmid">15821257</infon><infon key="section_type">REF</infon><infon key="source">Am J Physiol Renal Physiol</infon><infon key="type">ref</infon><infon key="volume">288</infon><infon key="year">2005</infon><offset>40721</offset><text>Segmental expression of Notch and Hairy genes in nephrogenesis</text></passage><passage><infon key="fpage">1030</infon><infon key="lpage">1034</infon><infon key="name_0">surname:Huang;given-names:TH</infon><infon key="name_1">surname:Laux;given-names:DE</infon><infon key="name_2">surname:Hamlin;given-names:BC</infon><infon key="pub-id_pmid">9067264</infon><infon key="section_type">REF</infon><infon key="source">Cancer Res</infon><infon key="type">ref</infon><infon key="volume">57</infon><infon key="year">1997</infon><offset>40784</offset><text>Identification of DNA methylation markers for human breast carcinomas using the methylation-sensitive restriction fingerprinting technique</text></passage><passage><infon key="fpage">251</infon><infon key="lpage">258</infon><infon key="name_0">surname:Hayashizaki;given-names:Y</infon><infon key="name_1">surname:Hirotsune;given-names:S</infon><infon key="name_2">surname:Okazaki;given-names:Y</infon><infon key="pub-id_pmid">8388788</infon><infon key="section_type">REF</infon><infon key="source">Electrophoresis</infon><infon key="type">ref</infon><infon key="volume">14</infon><infon key="year">1993</infon><offset>40923</offset><text>Restriction landmark genomic scanning method and its various applications</text></passage><passage><infon key="fpage">2307</infon><infon key="lpage">2312</infon><infon key="name_0">surname:Toyota;given-names:M</infon><infon key="name_1">surname:Ho;given-names:C</infon><infon key="name_2">surname:Ahuja;given-names:N</infon><infon key="pub-id_pmid">10344734</infon><infon key="section_type">REF</infon><infon key="source">Cancer Res</infon><infon key="type">ref</infon><infon key="volume">59</infon><infon key="year">1999</infon><offset>40997</offset><text>Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification</text></passage><passage><infon key="fpage">459</infon><infon key="lpage">470</infon><infon key="name_0">surname:Huang;given-names:TH</infon><infon key="name_1">surname:Perry;given-names:MR</infon><infon key="name_2">surname:Laux;given-names:DE.</infon><infon key="pub-id_pmid">9949205</infon><infon key="section_type">REF</infon><infon key="source">Hum Mol Genet</infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="year">1999</infon><offset>41111</offset><text>Methylation profiling of CpG islands in human breast cancer cells</text></passage><passage><infon key="fpage">1827</infon><infon key="lpage">1831</infon><infon key="name_0">surname:Frommer;given-names:M</infon><infon key="name_1">surname:McDonald;given-names:LE</infon><infon key="name_2">surname:Millar;given-names:DS</infon><infon key="pub-id_pmid">1542678</infon><infon key="section_type">REF</infon><infon key="source">Proc Natl Acad Sci USA</infon><infon key="type">ref</infon><infon key="volume">89</infon><infon key="year">1992</infon><offset>41177</offset><text>A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands</text></passage><passage><infon key="fpage">158</infon><infon key="lpage">164</infon><infon key="name_0">surname:Gitan;given-names:RS</infon><infon key="name_1">surname:Shi;given-names:H</infon><infon key="name_2">surname:Chen;given-names:CM</infon><infon key="pub-id_pmid">11779841</infon><infon key="section_type">REF</infon><infon key="source">Genome Res</infon><infon key="type">ref</infon><infon key="volume">12</infon><infon key="year">2002</infon><offset>41293</offset><text>Methylation-specific oligonucleotide microarray: a new potential for high-throughput methylation analysis</text></passage><passage><infon key="fpage">236</infon><infon key="lpage">244</infon><infon key="name_0">surname:Cross;given-names:SH</infon><infon key="name_1">surname:Charlton;given-names:JA</infon><infon key="name_2">surname:Nan;given-names:X</infon><infon key="pub-id_pmid">8012384</infon><infon key="section_type">REF</infon><infon key="source">Nat Genet</infon><infon key="type">ref</infon><infon key="volume">6</infon><infon key="year">1994</infon><offset>41399</offset><text>Purification of CpG islands using a methylated DNA binding column</text></passage><passage><infon key="fpage">315</infon><infon key="lpage">334</infon><infon key="name_0">surname:Oberley;given-names:MJ</infon><infon key="name_1">surname:Tsao;given-names:J</infon><infon key="name_2">surname:Yau;given-names:P</infon><infon key="pub-id_pmid">14975315</infon><infon key="section_type">REF</infon><infon key="source">Methods Enzymol</infon><infon key="type">ref</infon><infon key="volume">376</infon><infon key="year">2004</infon><offset>41465</offset><text>High-throughput screening of chromatin immunoprecipitates using CpG-island microarrays</text></passage><passage><infon key="fpage">e50</infon><infon key="name_0">surname:Tost;given-names:J</infon><infon key="name_1">surname:Schatz;given-names:P</infon><infon key="name_2">surname:Schuster;given-names:M</infon><infon key="pub-id_pmid">12711695</infon><infon key="section_type">REF</infon><infon key="source">Nucleic Acids Res</infon><infon key="type">ref</infon><infon key="volume">31</infon><infon key="year">2003</infon><offset>41552</offset><text>Analysis and accurate quantification of CpG methylation by MALDI mass spectrometry</text></passage></document></collection>
